US20220313888A1 - Bidirectional flow catheter - Google Patents
Bidirectional flow catheter Download PDFInfo
- Publication number
- US20220313888A1 US20220313888A1 US17/844,990 US202217844990A US2022313888A1 US 20220313888 A1 US20220313888 A1 US 20220313888A1 US 202217844990 A US202217844990 A US 202217844990A US 2022313888 A1 US2022313888 A1 US 2022313888A1
- Authority
- US
- United States
- Prior art keywords
- cannula
- patient
- blood
- flow port
- bidirectional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002457 bidirectional effect Effects 0.000 title claims abstract description 47
- 239000012530 fluid Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 abstract description 19
- 230000002612 cardiopulmonary effect Effects 0.000 abstract description 6
- 230000000747 cardiac effect Effects 0.000 abstract description 4
- 230000002093 peripheral effect Effects 0.000 abstract description 4
- 230000002792 vascular Effects 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 description 32
- 230000017531 blood circulation Effects 0.000 description 28
- 230000006378 damage Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 13
- 238000003780 insertion Methods 0.000 description 11
- 230000037431 insertion Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- -1 etc.) Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002787 reinforcement Effects 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000001631 vena cava inferior Anatomy 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 241001631457 Cannula Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0018—Catheters; Hollow probes having a plug, e.g. an inflatable plug for closing catheter lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M2025/0073—Tip designed for influencing the flow or the flow velocity of the fluid, e.g. inserts for twisted or vortex flow
Definitions
- the present invention relates generally to the field of medical devices, and more particularly to cannulae and systems using cannulae for peripheral extra corporeal life support (ECLS), including cardiac or pulmonary indication.
- ECLS extra corporeal life support
- Blood circulation in a person's heart and lungs is described here to provide a better understanding of certain aspects of embodiments of the invention as set forth herein.
- Blood travels in a patient's body to a patient's heart from the upper part of the body through the superior vena cava (SVC), and from the lower part of the body through the inferior vena cava (IVC), into the right atrium.
- SVC superior vena cava
- IVC inferior vena cava
- Blood moves both passively and actively through the right atrium and tricuspid valve into the right ventricle, which in turn contracts to force blood through the pulmonary valve and into the pulmonary artery.
- the pulmonary artery directs blood to the lungs, where the blood is oxygenated.
- the blood After the blood is oxygenated in the lungs, it returns to the heart through the pulmonary vein and into the left atrium.
- the left atrium both passively and actively allows blood through the mitral valve and into the left ventricle.
- the left ventricle then pumps the blood into the aorta, which then distributes the blood to the rest of the body.
- Blood flow in a patient's body, and particularly the oxygen carried by that person's blood as it courses through their body, is adversely affected by heart failure and lung disease, both of which are pervasive killers.
- Heart disease is a significant killer in the U.S., responsible for approximately 1 in 3 deaths (American Heart Association). Approximately 800,000 deaths annually are attributed to heart disease, despite billions in expenditures to fight the disease.
- extracorporeal life support ECLS
- ECLS extracorporeal life support
- ECLS In clinical practice, ECLS (and other practices including extracorporeal membrane oxygenation (“ECMO”)) requires a cannula, which is a medical tube inserted into the body for drainage and/or infusion of fluids, such as blood in the case of ECLS.
- the major problems of available cannulae for ECLS include: (1) cannulation and insertion of cannulae with larger diameters causing extra trauma to patients; (2) the cannula placed in an artery can obstruct distal blood flow due to its large diameter; and (3) damage to adjacent tissue during placement and/or removal.
- 2014/0330250 to Moshinsky et al. disclose a cannula having a first aperture at a distal end and a second aperture positioned proximally to the distal end, with a protuberance at the second aperture that engages the wall of the patient's blood vessel to prevent its collapse during use.
- prior efforts have shortcomings, in that they typically exhibit sharp surfaces or facing edges that make it difficult for an operator to place and remove the cannula from the patient's artery, and increase risk of injury to the patient during placement and/or removal.
- such previously known configurations are prone to movement with respect to the patient's artery as the patient moves, risking dislodgement, bleeding, and general injury to the patient.
- a bidirectional intravascular cannula or catheter, is provided that is configured to provide and return blood bidirectionally.
- the cannula can provide blood to a patient's blood vessel, such as to a patient's arteries, without causing significant blockage that can reduce blood flow to the patient's limbs, even if the cannula is placed proximally in the blood vessel.
- the bidirectional intravascular cannula reduces or obviates the need for a second or distal cannula to be placed in a second or opposite direction of flow of currently available unidirectional cannulae.
- This bidirectional intravascular cannula provides bidirectional flow via a biocompatible reverse flow port.
- the cannula can be used, by way of non-limiting example, by cardiac surgeons, intensivists, vascular surgeons, ER doctors, IR doctors and cardiologists for peripheral cannulation for ECLS or cardiopulmonary bypass during heart surgery.
- a bidirectional flow catheter system comprising: a cannula having a distal end and a proximal end opposite the distal end; a forward flow port at the distal end of the cannula, the forward flow port configured to direct fluid from the cannula in a first direction; a reverse flow port positioned proximally from the distal end of the cannula, the reverse flow port configured to direct fluid from the cannula in a second direction; and a cap positioned on an exterior of the cannula and extending over the reverse flow port.
- a bidirectional flow catheter system comprising: a cannula having a forward flow port at a distal end thereof and a reverse flow port positioned proximally to the distal end; and an obdurator having an outer diameter approximately equal to an interior diameter of the cannula at the distal end of the cannula, the obdurator having a channel in a side wall of the obdurator, the channel having a distal channel end that is proximal to a distal end of the obdurator and a proximal end adjacent to a widened-diameter portion of the cannula; wherein the channel is positioned on the obdurator to align with the reverse flow port when the obdurator is fully inserted into the cannula.
- FIG. 1 is a side view of a bidirectional flow catheter in a blood vessel of a patient in accordance with certain aspects of an embodiment of the invention.
- FIG. 1A is a close-up side view of a reverse flow port on the bidirectional flow catheter of FIG. 1 .
- FIG. 2 is a side view of the bidirectional flow catheter of FIG. 1 in a common femoral artery.
- FIG. 3 is a cross-sectional view of the bidirectional flow catheter of FIG. 1 in a blood vessel and showing a blood flow direction.
- FIG. 4 is a close-up, cross-section view of a reverse flow port on the bidirectional flow catheter of FIG. 1 and showing a blood flow direction.
- FIG. 5 is a top view of the reverse flow port on the bidirectional flow catheter of FIG. 1 .
- FIG. 6 is a top view of the reverse flow port on the bidirectional flow catheter of FIG. 1 and showing cross-section lines.
- FIG. 6A is a lateral cross-sectional view of the bidirectional flow catheter of FIG. 1 along section line A-A of FIG. 6 .
- FIG. 6B is a lateral cross-sectional view of the bidirectional flow catheter of FIG. 1 along section line B-B of FIG. 6 .
- FIG. 6C is a lateral cross-sectional view of the bidirectional flow catheter of FIG. 1 along section line C-C of FIG. 6 .
- FIG. 7 is a side view of the bidirectional flow catheter of FIG. 1 .
- FIG. 8 is a top view of the bidirectional flow catheter of FIG. 1 .
- FIG. 9 is a close-up perspective view of the reverse flow port on the bidirectional flow catheter of FIG. 1 .
- FIG. 10A is a close-up, side perspective cross-sectional view of the bidirectional flow catheter of FIG. 1 in a blood vessel at the location of the reverse flow port.
- FIG. 10B is close-up, front perspective cross-sectional view of the bidirectional flow catheter of FIG. 1 in a blood vessel at the location of the reverse flow port.
- FIG. 11 is a close-up, side view of the bidirectional flow catheter of FIG. 1 showing exemplary dimensions of portions of the reverse flow port.
- FIG. 12 is a close-up, front view of the reverse flow port on the bidirectional flow catheter of FIG. 1 showing exemplary dimensions of portions of the reverse flow port.
- FIG. 13 is a close-up, side perspective view of the bidirectional flow catheter of FIG. 1 with a cap over the aperture of the reverse flow port shown in phantom.
- FIG. 14 is a close-up, top view of the aperture of the reverse flow port showing exemplary dimensions of the aperture.
- FIG. 15 is a close-up, side view of the cap of the reverse flow port showing exemplary dimensions of the cap.
- FIG. 16 is a close-up, top view of the cap of the reverse flow port.
- FIG. 17 is a top, side perspective, horizontal cross-sectional view of the bidirectional flow catheter of FIG. 1 and showing a flow direction.
- FIG. 18 is a close-up, top horizontal cross-sectional view of the bidirectional flow catheter of FIG. 1 showing a flow direction from the lumen of the cannula into the reverse flow port.
- FIG. 19 is a top, side perspective, vertical cross-sectional view of the bidirectional flow catheter of FIG. 1 and showing a flow direction.
- FIG. 20 is a side view of the bidirectional flow catheter of FIG. 1 with an obdurator full inserted into the catheter.
- FIG. 21 is a bottom view of the obdurator of FIG. 20 .
- X, Y, and Z can be construed as X only, Y only, Z only, or any combination of two or more items X, Y, and Z (e.g., XYZ, XZ, XYY, YZ, ZZ). Further, it will be understood that when an element is referred to as being “connected to” another element, it can be directly connected to the other element, or intervening elements may be present.
- first”, “second”, and the like does not imply any particular order, but they are included to identify individual elements. Moreover, the use of the terms first, second, etc. does not denote any order of importance, but rather the terms first, second, etc. are used to distinguish one element from another. It will be further understood that the terms “comprises” and/or “comprising”, or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.
- a bidirectional intravascular cannula 100 or catheter is provided, which in certain configurations may be used in peripheral ECLS, such as extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass to provide and return blood bidirectionally to a patient's blood vessel.
- the cannula 100 is a single cannula that is configured to provide bidirectional blood flow using a reverse flow port 110 .
- the cannula 100 can be inserted into a patient's blood vessel to provide blood in a first direction from a distal end 124 of the cannula 100 , such as toward the patient's heart, and in a second direction (preferably opposite to the first direction) from a reverse flow port 110 , such as to flow toward the distal portion of the patient's limb in which cannula 100 has been placed.
- a second cannula such as a currently available unidirectional cannula used in veno-arterial ECLS procedures, to be placed in a second or opposite direction of flow.
- the cannula 100 is further configured to be inserted into the patient at an insertion location while reducing damage to tissue adjacent to the insertion location, compared to typical cannula.
- the cannula 100 is still further configured to remain stably positioned in the patient at the insertion location of the patient when perturbed, such as when the patient moves or when a line coupled to the cannula 100 is perturbed.
- This bidirectional intravascular cannula 100 provides bidirectional blood flow via reverse flow port 110 and forward flow port 112 at the distal end 124 of cannula 100 , as further discussed below, which are biocompatible.
- cannula 100 includes a cannula lumen 114 extending through cannula 100 from a proximal end 122 to a distal end 124 of cannula 100 , a forward flow port 112 at distal end 124 of cannula 100 , a reverse flow port 110 positioned proximally from distal end 124 of cannula 100 and extending through a sidewall of cannula 100 from an exterior of cannula 100 into lumen 114 , a cap 116 on the exterior wall of cannula 100 extending over most or all of reverse flow port 110 , and a coupling 118 adjacent the proximal end 122 of cannula 100 .
- the lumen 114 of cannula 100 is a generally arcuate lumen having a proximal end that coincides with the proximal end 122 of cannula 100 , and a distal end that coincides with distal end 124 of cannula 100 , and is configured to fluidly and percutaneously communicate blood from an inlet portion 126 of cannula 100 to an outlet portion 128 of cannula 100 .
- the inlet portion 126 is integrally formed with coupling 118 at the proximal end 122 of cannula 100
- the outlet portion 128 includes the reverse flow port 110 and the forward flow port 112 near the distal end 124 of the cannula 100 .
- Coupling 118 is configured to couple and operate with typical ECLS tubing and equipment (not shown).
- the cannula lumen 114 of the current embodiment can be various diameters, similar to typical cannulas, such as 12-25 French, although other diameters may be employed for particular situations as desired by an operator without departing from the spirit and scope of the invention.
- the general arcuate cannula lumen 114 does not have a particularly fixed angle between the proximal end 122 and distal end 124 of cannula 100 .
- the general arcuate cannula lumen 114 can have an angle between the proximal end 122 and distal end 124 of approximately 15 degrees, or between 5 degrees and 180 degrees.
- Cannula 100 is preferably formed of a biocompatible material, such as a metal (e.g., alloy, stainless steel, titanium, etc.), plastic (e.g., PEEK, PMMA, Nylon, Polyurethane, etc.), ceramic, composite, or the like.
- a metal e.g., alloy, stainless steel, titanium, etc.
- plastic e.g., PEEK, PMMA, Nylon, Polyurethane, etc.
- ceramic composite, or the like.
- cannula 100 is formed as one piece of material; however, cannula 100 may alternatively be formed of multiple pieces of material (e.g., the cannula 100 is formed as one component and the coupling 118 and/or cap 116 are formed as another component that are attached to the cannula 100 component).
- cannula 100 can be formed according to many typical manufacturing methods, such as dipping, machining, injection molding, lay-ups, additive manufacturing methods, and the like. Still further, cannula 100 may include a biocompatible coating (such as polyethylene or the like) to protect cannula 100 , reduce friction, or improve flow. In certain configurations, cannula 100 may include structural reinforcement to increase the strength and rigidity of the cannula 100 , as shown in FIG. 2 . By way of non-limiting example, such structural reinforcement may comprise a thin reinforcement wire 138 , which is generally covered by a coating (such as the biocompatible coating discussed above) to provide a smooth surface.
- a coating such as the biocompatible coating discussed above
- reverse flow port 110 is configured to provide blood flow in a different and preferably reverse direction relative to blood flow within the cannula lumen 114 and from the forward flow port 112 .
- FIGS. 3 and 4 show the cannula 100 providing for blood flowing through the cannula lumen 114 from the proximal end 122 of cannula 100 to the forward flow port 112 , and the reverse flow port 110 configured to provide blood flow from the cannula lumen 114 into the blood vessel away from the forward flow port 112 (i.e., away from the distal end 124 of cannula 100 ).
- FIG. 3 and 4 show the cannula 100 providing for blood flowing through the cannula lumen 114 from the proximal end 122 of cannula 100 to the forward flow port 112 , and the reverse flow port 110 configured to provide blood flow from the cannula lumen 114 into the blood vessel away from the forward flow port 112 (i.e., away from the distal end 124 of cannul
- a distal end of reverse flow port 110 is positioned 5 cm from the distal end 124 of cannula 100 so as to ensure adequate flow in both directions without excessive turbulence or other interference between the flows.
- the outer surface of cap 116 over reverse flow port 110 is further configured to reduce damage (e.g., compared to a typical ECLS cannula) to the patient's tissue (e.g., skin, muscle, and blood vessels) when placing, inserting, or removing the cannula 100 .
- cannula 100 is placed into a patient's blood vessel according to typical methods and guidelines.
- cap 116 over reverse flow port 110 is still further configured to reduce the likelihood that the cannula 100 will inadvertently displace from the patient, for example, when cannula 100 is perturbed or the patient moves, and also reduce damage to the patient's tissue if cannula 100 is perturbed or inadvertently displaced from the patient, compared to a typical cannula.
- reverse flow port 110 includes an aperture 130 or hole (see FIGS. 4, 5, 9, 13, 14, and 17-19 ) extending through the wall of cannula 100 from lumen 114 to the exterior of cannula 100 .
- the aperture 130 is configured to fluidly communicate blood flow from the cannula lumen 114 to the patient's blood vessel. More particularly, a portion of blood flowing through lumen 114 toward distal end 124 of cannula 100 will escape through aperture 130 before it reaches distal end 124 of cannula 100 .
- the interior of cap 116 is configured to generally direct blood flow that escapes from lumen 114 through aperture 130 in a desired direction, such as a direction opposite to the direction of blood flow from the forward flow port 112 , while the exterior of cap 116 is configured to reduce the likelihood of damage to the patient's tissue, as described herein.
- the combination of the cap 116 configured as described herein and aperture 130 fluidly communicate blood flow from the cannula lumen 114 to the patient's blood vessel, as described above, while providing preferential blood flow properties, such as desired blood flow velocity and reducing turbulence.
- the reverse flow port 110 and the forward flow port 112 are spaced relative to each other along the cannula lumen 114 , such as by a distance of 5 cm, to reduce the likelihood of damage, etc., as described above (see, e.g., FIG. 2 ).
- the reverse flow port 110 can be displaced approximately 5 cm from the forward flow port 112 .
- the reverse flow port 110 can be displaced approximately 5 cm forward of the insertion point of the cannula 100 into the patient's blood vessel.
- the reverse flow port 110 is displaced distal of an arcuate portion of the cannula 100 , such as positioned on a straight portion of the cannula 100 .
- cap 116 is on the exterior of cannula 100 and generally covers aperture 130 .
- the exterior of cap 116 generally has a convex, parabolic, and ramp-like shape, such that the cap 116 fluidly communicates blood flow in one direction only.
- the cap 116 can be configured to communicate blood flow in a plurality of directions. As shown in the top views of cap 116 of FIGS.
- cap 116 generally has a parabola-like outline, such that it is formed by a body portion 132 that has a ramp-like shape that intersects a bottom portion 120 of the exterior of cannula 100 , and a leg portion 134 (e.g., having two leg-like shapes 134 a and 134 b ) that generally intersects with side portions 136 of the exterior of cannula 100 (see FIGS. 5, 6, 6B, and 6C ).
- Body portion 132 of cap 116 is generally convex to direct blood flow in a desired direction while reducing the likelihood of inducing turbulence.
- the exterior of the body portion 132 of the cap 116 is generally configured to rest on an inner wall of a patient's blood vessel, such that the inner wall of the blood vessel does not substantially interfere with blood flow between aperture 130 and the blood vessel.
- the exterior surface of cap 116 is configured to contact and displace the inner wall of the blood vessel so as to optimally position aperture 130 with respect to the inner wall of the blood vessel.
- cap 116 may have a height (from the exterior of cannula 100 to the interior face of cap 116 ) of, for example, between 0.5 mm and 3 mm, and more preferably between 0.8 mm and 2 mm, and most preferably 1 mm, with the wall of cap 116 having a thickness of preferably between 0.05 mm and 2 mm, and more preferably of 0.2 mm, and a maximum width at a proximal end of cap 116 of preferably 4 mm.
- cap 116 a shape that is configured to slide on the patient's tissue without entangling or snaring the patient's tissue to reduce the likelihood of damage to the patient's tissue when placing the cannula 100 in the patient and when removing the cannula 100 from the patient (e.g., desired or inadvertent), as described above, such that cap 116 has no substantially sharp, abrupt, or barb-like surfaces.
- body portion 132 and leg portion 134 of cap 116 are configured to achieve the desired flow properties.
- the body portion 132 generally forms the parabola-like outline of the cap 116 , and extends from the cannula lumen 114 to the leg portion 134 at a ramp angle.
- the ramp angle (“A” of FIG. 11 ) of body portion 132 of cap 116 reduces the likelihood of damage to the patient's tissue during insertion by providing a substantially smooth surface, as discussed above.
- leg portion 134 of cap 116 reduces the likelihood of damage to the patient's tissue during removal, with both body portion 132 and leg portion 134 having no substantially sharp, abrupt, or barb-like surfaces.
- the ramp angle A of body portion 132 is preferably in the range of 10 degrees to 70 degrees, and more preferably in the range of 15 degrees to 22 degrees.
- the ramp angle B of leg portion is preferably in the range of 10 degrees to 70 degrees, and more preferably 20 degrees.
- Leg portion 134 includes two elongated leg-like features 134 a and 134 b that each extend from the body portion 132 on the bottom portion 120 of cannula 100 to the side portions 136 of cannula 100 .
- cap 116 is particularly configured to reduce the likelihood of cross-flow (e.g., blood flow in the blood vessel between the reverse flow port 110 and the forward flow port 112 ) by reducing the likelihood of blood flow around the leg portion 134 .
- the leg portion 134 is generally angled from the side portions 136 of the cannula lumen 114 to the body portion 132 , such that the leg portion 134 generally has an arcuate and concave outline (best viewed in FIG. 1A ).
- the angle of the leg portion 134 may vary according to various properties of the cannula 100 , such as the cannula lumen diameter, the desired blood flow properties (e.g., direction, velocity, turbulence), and placement location.
- the angle of the leg portion 134 and concave outline may be selected to reduce the likelihood of damage to the patient's tissue by providing a smooth surface, as discussed above, such as having no substantially sharp, abrupt, or barb-like surfaces.
- the leg-like features 134 a and 134 b may have unequal angles and/or arcuate shapes.
- Aperture 130 is configured to fluidly communicate blood flow from the cannula lumen 114 to the patient's blood vessel.
- aperture 130 of the current embodiment has a parabola-like opening similar to the parabola-like outline of the cap 116 , as shown in FIGS. 5 and 14 , in which the vertex of the parabola is located at the distal-most portion of aperture 130 (closest to forward flow port 112 ).
- aperture 130 may have a different opening size or shape compared to the cap 116 .
- aperture 130 has an opening size that is generally similar to the diameter of the cannula lumen 114 , such as 12-23 French. For example, FIG.
- FIG. 5 shows a top view of cap 116 (shaded) and aperture 130 (dashed line) that do not strictly overlap, but have a generally similar outline.
- the aperture 130 has an opening that is approximately 4 mm wide and approximately 7 mm long.
- aperture 130 may have an ellipsoidal-like opening as shown in FIG. 4 .
- forward flow port 112 is configured to fluidly communicate blood from the cannula lumen 114 into the patient's blood vessel in a proximal direction (e.g., towards the heart and other arteries).
- forward flow port 112 has a cross-sectional opening that is similar to the cross-section of cannula 100
- reverse flow port 110 is configured to communicate blood flow from the cannula lumen 114 into the blood vessel away from the forward flow port 112 (e.g., away from the distal end 124 of cannula 100 ).
- forward flow port 112 may include a plurality of apertures or fenestrations.
- Coupling 118 adjacent proximal end 122 of cannula 100 may be configured to attach to standard medical equipment, such as ECLS devices or any device for circulating blood through a major blood vessel having blood flow in an opposing direction, such as cardiac bypass, mechanical arterial support, venous access device (VAD) support, or the like.
- standard medical equipment such as ECLS devices or any device for circulating blood through a major blood vessel having blood flow in an opposing direction, such as cardiac bypass, mechanical arterial support, venous access device (VAD) support, or the like.
- VAD venous access device
- an obdurator 200 may be provided for use with cannula 100 for placement of cannula 100 within a patient's blood vessel.
- Obdurator 200 is a solid member having an outside diameter approximately the same as the inside diameter of cannula lumen 114 at the distal end 124 of cannula 100 , and is sufficiently long so that the distal end 202 of obdurator 200 , when inserted in cannula 100 , extends beyond the distal end 124 of cannula 100 .
- obdurator 200 In use, access may be gained to the vessel (such as by making an incision) and the obdurator 200 is inserted into cannula 100 , with distal end 202 of obdurator 200 extending beyond the distal end 124 of cannula 100 . Obdurator 200 then pushes through the patient's soft tissue and into the patient's blood vessel, gaining entrance for cannula 200 . Once inserted in place, obdurator 200 is removed, leaving cannula 100 in place in the patient's blood vessel.
- Obdurator 200 is particularly configured to enable an operator to know when reverse flow port 110 is positioned within the patient's blood vessel. More particularly, obdurator 200 includes a concave channel 204 extending into the surface of obdurator 200 . Concave channel has a distal end closest to distal end 124 of lumen 114 that, when obdurator 200 is fully inserted into cannula 100 , aligns with or is distal to reverse flow port 110 (as show in FIG. 20 ).
- Channel 204 allows blood to flow in cannula 100 when obdurator 200 is in place within cannula 100 , with such blood flowing from the patient's blood vessel into reverse flow port 110 , into channel 204 , and proximally through channel 204 (toward the proximal end 122 of cannula 100 ) into a widened section 138 of cannula 100 and ultimately toward preferably a luer locked hole (not shown) positioned near proximal end of cannula 100 , such as on coupling 118 .
- the distal end of concave channel 204 aligns with reverse flow port 110 .
- concave channel 204 has a depth into the surface of obdurator 200 and a width that is 5-30% of the diameter of obdurator 200 .
- a bidirectional intravascular cannula or catheter, that is configured to provide and return blood bidirectionally.
- the bidirectional intravascular cannula reduces or obviates the need for a second cannula to be placed in a second or opposite direction of flow of currently available unidirectional cannulae.
- the cannula is further configured to be inserted into the patient at an insertion location while reducing damage to tissue, compared to typical cannula, which is adjacent to that insertion location.
- This bidirectional intravascular cannula provides bidirectional flow via a biocompatible, reverse flow port.
- the cannula is further configured to stably remain in the patient at the insertion location of the patient when perturbed, such as when the patient moves slightly or when a line coupled to the cannula is perturbed.
- This bidirectional intravascular cannula provides bidirectional flow via a reverse flow port and the forward flow port, which are biocompatible.
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 16/754,382 titled “BIDIRECTIONAL FLOW CATHETER,” filed Apr. 8, 20202, now. U.S. Pat. No. 11,364,333, which is a national stage entry of International Patent Application No. PCT/US2018/055160, titled “BIDIRECTIONAL FLOW CATHETER,” filed Oct. 10, 2018, which is based upon and claims the benefit of U.S. Provisional Application No. 62/570,148 titled “BIDIRECTIONAL FLOW CATHETER,” filed with the United States Patent & Trademark Office on Oct. 10, 2017, the specification of which is incorporated herein by reference in its entirety.
- The present invention relates generally to the field of medical devices, and more particularly to cannulae and systems using cannulae for peripheral extra corporeal life support (ECLS), including cardiac or pulmonary indication.
- Blood circulation in a person's heart and lungs is described here to provide a better understanding of certain aspects of embodiments of the invention as set forth herein. Blood travels in a patient's body to a patient's heart from the upper part of the body through the superior vena cava (SVC), and from the lower part of the body through the inferior vena cava (IVC), into the right atrium. Blood moves both passively and actively through the right atrium and tricuspid valve into the right ventricle, which in turn contracts to force blood through the pulmonary valve and into the pulmonary artery. The pulmonary artery directs blood to the lungs, where the blood is oxygenated.
- After the blood is oxygenated in the lungs, it returns to the heart through the pulmonary vein and into the left atrium. The left atrium both passively and actively allows blood through the mitral valve and into the left ventricle. The left ventricle then pumps the blood into the aorta, which then distributes the blood to the rest of the body. Blood flow in a patient's body, and particularly the oxygen carried by that person's blood as it courses through their body, is adversely affected by heart failure and lung disease, both of which are pervasive killers.
- Heart disease is a significant killer in the U.S., responsible for approximately 1 in 3 deaths (American Heart Association). Approximately 800,000 deaths annually are attributed to heart disease, despite billions in expenditures to fight the disease. When the heart fails to pump an adequate amount of blood, extracorporeal life support (ECLS) can be utilized to bypass the heart and lungs and pump oxygenated blood to the body.
- In clinical practice, ECLS (and other practices including extracorporeal membrane oxygenation (“ECMO”)) requires a cannula, which is a medical tube inserted into the body for drainage and/or infusion of fluids, such as blood in the case of ECLS. The major problems of available cannulae for ECLS include: (1) cannulation and insertion of cannulae with larger diameters causing extra trauma to patients; (2) the cannula placed in an artery can obstruct distal blood flow due to its large diameter; and (3) damage to adjacent tissue during placement and/or removal.
- Thus, currently available arterial cannulae used for cardiopulmonary bypass during surgery and veno-arterial ECLS can obstruct distal flow to the limb in which the cannula is inserted (e.g., the lower leg with femoral cannulation). This can lead to devastating ischemic injury of that limb. Previous efforts to alleviate that risk having included placement of a smaller than desirable sized cannula that will not obstruct the vessel proximally to the point of insertion, or the placement of an additional catheter distally to the point of insertion of the cannula to provide flow to the distal portion of the limb.
- Further efforts have been made to provide for distal perfusion, including efforts to provide cannulae with a secondary port positioned proximally to the distal end of the cannula, which secondary port is intended to allow blood to flow into the artery in a direction opposite the flow direction from the distal end of the cannula. For example, U.S. Pat. Nos. 5,171,218 and 5,330,433 to Fonger et al. are directed to an arterial cannula having a diverting side hole positioned proximally on the cannula from the distal end, with barbs on the exterior of the cannula on opposite sides of the diverting side hole. Further, U.S. Pat. No. 8,795,253 and U.S. Patent Application Pub. No. 2014/0330250 to Moshinsky et al. disclose a cannula having a first aperture at a distal end and a second aperture positioned proximally to the distal end, with a protuberance at the second aperture that engages the wall of the patient's blood vessel to prevent its collapse during use. However, such prior efforts have shortcomings, in that they typically exhibit sharp surfaces or facing edges that make it difficult for an operator to place and remove the cannula from the patient's artery, and increase risk of injury to the patient during placement and/or removal. Moreover, such previously known configurations are prone to movement with respect to the patient's artery as the patient moves, risking dislodgement, bleeding, and general injury to the patient.
- Accordingly, there remains a need in the art for a device, systems, and methods that will reduce the harm associated with cannulae used during ECLS, that will minimize the risk of blood flow obstruction and damage to the patient's tissue, and that particularly will offer a minimally invasive, efficient, and simple percutaneous cannula for use with ECLS and cardiopulmonary bypass procedures.
- Disclosed herein are devices and methods configured to address one or more of the above described disadvantages of the prior art. However, achieving the above purposes and/or benefits is not a necessary feature to each of the exemplary embodiments, and the claims herein may recite subject matter that does not achieve the above stated purposes.
- In accordance with certain aspects of an embodiment of the invention, a bidirectional intravascular cannula, or catheter, is provided that is configured to provide and return blood bidirectionally. For example, the cannula can provide blood to a patient's blood vessel, such as to a patient's arteries, without causing significant blockage that can reduce blood flow to the patient's limbs, even if the cannula is placed proximally in the blood vessel. Thus, the bidirectional intravascular cannula reduces or obviates the need for a second or distal cannula to be placed in a second or opposite direction of flow of currently available unidirectional cannulae. This bidirectional intravascular cannula provides bidirectional flow via a biocompatible reverse flow port. The cannula can be used, by way of non-limiting example, by cardiac surgeons, intensivists, vascular surgeons, ER doctors, IR doctors and cardiologists for peripheral cannulation for ECLS or cardiopulmonary bypass during heart surgery.
- In accordance with further aspects of an embodiment of the invention, a bidirectional flow catheter system is provided, comprising: a cannula having a distal end and a proximal end opposite the distal end; a forward flow port at the distal end of the cannula, the forward flow port configured to direct fluid from the cannula in a first direction; a reverse flow port positioned proximally from the distal end of the cannula, the reverse flow port configured to direct fluid from the cannula in a second direction; and a cap positioned on an exterior of the cannula and extending over the reverse flow port.
- In accordance with still further aspects of an embodiment of the invention, a bidirectional flow catheter system is provided, comprising: a cannula having a forward flow port at a distal end thereof and a reverse flow port positioned proximally to the distal end; and an obdurator having an outer diameter approximately equal to an interior diameter of the cannula at the distal end of the cannula, the obdurator having a channel in a side wall of the obdurator, the channel having a distal channel end that is proximal to a distal end of the obdurator and a proximal end adjacent to a widened-diameter portion of the cannula; wherein the channel is positioned on the obdurator to align with the reverse flow port when the obdurator is fully inserted into the cannula.
- The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention, and together with the description serve to explain the principles of the invention.
-
FIG. 1 is a side view of a bidirectional flow catheter in a blood vessel of a patient in accordance with certain aspects of an embodiment of the invention. -
FIG. 1A is a close-up side view of a reverse flow port on the bidirectional flow catheter ofFIG. 1 . -
FIG. 2 is a side view of the bidirectional flow catheter ofFIG. 1 in a common femoral artery. -
FIG. 3 is a cross-sectional view of the bidirectional flow catheter ofFIG. 1 in a blood vessel and showing a blood flow direction. -
FIG. 4 is a close-up, cross-section view of a reverse flow port on the bidirectional flow catheter ofFIG. 1 and showing a blood flow direction. -
FIG. 5 is a top view of the reverse flow port on the bidirectional flow catheter ofFIG. 1 . -
FIG. 6 is a top view of the reverse flow port on the bidirectional flow catheter ofFIG. 1 and showing cross-section lines. -
FIG. 6A is a lateral cross-sectional view of the bidirectional flow catheter ofFIG. 1 along section line A-A ofFIG. 6 . -
FIG. 6B is a lateral cross-sectional view of the bidirectional flow catheter ofFIG. 1 along section line B-B ofFIG. 6 . -
FIG. 6C is a lateral cross-sectional view of the bidirectional flow catheter ofFIG. 1 along section line C-C ofFIG. 6 . -
FIG. 7 is a side view of the bidirectional flow catheter ofFIG. 1 . -
FIG. 8 is a top view of the bidirectional flow catheter ofFIG. 1 . -
FIG. 9 is a close-up perspective view of the reverse flow port on the bidirectional flow catheter ofFIG. 1 . -
FIG. 10A is a close-up, side perspective cross-sectional view of the bidirectional flow catheter ofFIG. 1 in a blood vessel at the location of the reverse flow port. -
FIG. 10B is close-up, front perspective cross-sectional view of the bidirectional flow catheter ofFIG. 1 in a blood vessel at the location of the reverse flow port. -
FIG. 11 is a close-up, side view of the bidirectional flow catheter ofFIG. 1 showing exemplary dimensions of portions of the reverse flow port. -
FIG. 12 is a close-up, front view of the reverse flow port on the bidirectional flow catheter ofFIG. 1 showing exemplary dimensions of portions of the reverse flow port. -
FIG. 13 is a close-up, side perspective view of the bidirectional flow catheter ofFIG. 1 with a cap over the aperture of the reverse flow port shown in phantom. -
FIG. 14 is a close-up, top view of the aperture of the reverse flow port showing exemplary dimensions of the aperture. -
FIG. 15 is a close-up, side view of the cap of the reverse flow port showing exemplary dimensions of the cap. -
FIG. 16 is a close-up, top view of the cap of the reverse flow port. -
FIG. 17 is a top, side perspective, horizontal cross-sectional view of the bidirectional flow catheter ofFIG. 1 and showing a flow direction. -
FIG. 18 is a close-up, top horizontal cross-sectional view of the bidirectional flow catheter ofFIG. 1 showing a flow direction from the lumen of the cannula into the reverse flow port. -
FIG. 19 is a top, side perspective, vertical cross-sectional view of the bidirectional flow catheter ofFIG. 1 and showing a flow direction. -
FIG. 20 is a side view of the bidirectional flow catheter ofFIG. 1 with an obdurator full inserted into the catheter. -
FIG. 21 is a bottom view of the obdurator ofFIG. 20 . - The following detailed description is provided to gain a comprehensive understanding of the methods, apparatuses and/or systems described herein. Various changes, modifications, and equivalents of the systems, apparatuses and/or methods described herein will suggest themselves to those of ordinary skill in the art. Descriptions of well-known functions and structures are omitted to enhance clarity and conciseness.
- Hereinafter, an apparatus and method for enabling bidirectional flow during extracorporeal life support (ECLS) or cardiopulmonary bypass is disclosed. Embodiments of the invention may, however, be configured in many different forms for various other procedures and should not be construed as limited to the exemplary embodiments set forth herein. Rather, these exemplary embodiments are provided so that this disclosure is thorough, and will fully convey the scope of the invention to those skilled in the art.
- Throughout the drawings and the detailed description, unless otherwise described, the same drawing reference numerals are understood to refer to the same elements, features, and structures. The relative size and depiction of these elements may be exaggerated for clarity.
- It will be understood that for the purposes of this disclosure, “at least one of X, Y, and Z” can be construed as X only, Y only, Z only, or any combination of two or more items X, Y, and Z (e.g., XYZ, XZ, XYY, YZ, ZZ). Further, it will be understood that when an element is referred to as being “connected to” another element, it can be directly connected to the other element, or intervening elements may be present.
- The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the present disclosure. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Furthermore, the use of the terms a, an, etc. does not denote a limitation of quantity, but rather denotes the presence of at least one of the referenced item.
- The use of the terms “first”, “second”, and the like does not imply any particular order, but they are included to identify individual elements. Moreover, the use of the terms first, second, etc. does not denote any order of importance, but rather the terms first, second, etc. are used to distinguish one element from another. It will be further understood that the terms “comprises” and/or “comprising”, or “includes” and/or “including” when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.
- Although some features may be described with respect to individual exemplary embodiments, aspects need not be limited thereto such that features from one or more exemplary embodiments may be combinable with other features from one or more exemplary embodiments.
- Referring to
FIGS. 1-21 , a bidirectionalintravascular cannula 100 or catheter is provided, which in certain configurations may be used in peripheral ECLS, such as extracorporeal membrane oxygenation (ECMO) or cardiopulmonary bypass to provide and return blood bidirectionally to a patient's blood vessel. In an exemplary embodiment, thecannula 100 is a single cannula that is configured to provide bidirectional blood flow using areverse flow port 110. For example, thecannula 100 can be inserted into a patient's blood vessel to provide blood in a first direction from adistal end 124 of thecannula 100, such as toward the patient's heart, and in a second direction (preferably opposite to the first direction) from areverse flow port 110, such as to flow toward the distal portion of the patient's limb in which cannula 100 has been placed. Thus, the bidirectionalintravascular cannula 100 reduces or obviates the need for a second cannula, such as a currently available unidirectional cannula used in veno-arterial ECLS procedures, to be placed in a second or opposite direction of flow. As discussed below, thecannula 100 is further configured to be inserted into the patient at an insertion location while reducing damage to tissue adjacent to the insertion location, compared to typical cannula. Thecannula 100 is still further configured to remain stably positioned in the patient at the insertion location of the patient when perturbed, such as when the patient moves or when a line coupled to thecannula 100 is perturbed. This bidirectionalintravascular cannula 100 provides bidirectional blood flow viareverse flow port 110 and forward flowport 112 at thedistal end 124 ofcannula 100, as further discussed below, which are biocompatible. - With particular reference to
FIGS. 1, 2, 5, 7 and 8 ,cannula 100 according to certain aspects of an embodiment includes acannula lumen 114 extending throughcannula 100 from aproximal end 122 to adistal end 124 ofcannula 100, aforward flow port 112 atdistal end 124 ofcannula 100, areverse flow port 110 positioned proximally fromdistal end 124 ofcannula 100 and extending through a sidewall ofcannula 100 from an exterior ofcannula 100 intolumen 114, acap 116 on the exterior wall ofcannula 100 extending over most or all ofreverse flow port 110, and acoupling 118 adjacent theproximal end 122 ofcannula 100. Thelumen 114 ofcannula 100 is a generally arcuate lumen having a proximal end that coincides with theproximal end 122 ofcannula 100, and a distal end that coincides withdistal end 124 ofcannula 100, and is configured to fluidly and percutaneously communicate blood from aninlet portion 126 ofcannula 100 to anoutlet portion 128 ofcannula 100. For example, in one embodiment theinlet portion 126 is integrally formed withcoupling 118 at theproximal end 122 ofcannula 100, and theoutlet portion 128 includes thereverse flow port 110 and theforward flow port 112 near thedistal end 124 of thecannula 100. Coupling 118 is configured to couple and operate with typical ECLS tubing and equipment (not shown). Thecannula lumen 114 of the current embodiment can be various diameters, similar to typical cannulas, such as 12-25 French, although other diameters may be employed for particular situations as desired by an operator without departing from the spirit and scope of the invention. - In a particular embodiment, the general
arcuate cannula lumen 114 does not have a particularly fixed angle between theproximal end 122 anddistal end 124 ofcannula 100. For example, the generalarcuate cannula lumen 114 can have an angle between theproximal end 122 anddistal end 124 of approximately 15 degrees, or between 5 degrees and 180 degrees. -
Cannula 100 is preferably formed of a biocompatible material, such as a metal (e.g., alloy, stainless steel, titanium, etc.), plastic (e.g., PEEK, PMMA, Nylon, Polyurethane, etc.), ceramic, composite, or the like. In an exemplary embodiment,cannula 100 is formed as one piece of material; however, cannula 100 may alternatively be formed of multiple pieces of material (e.g., thecannula 100 is formed as one component and thecoupling 118 and/orcap 116 are formed as another component that are attached to thecannula 100 component). Furthermore,cannula 100 can be formed according to many typical manufacturing methods, such as dipping, machining, injection molding, lay-ups, additive manufacturing methods, and the like. Still further,cannula 100 may include a biocompatible coating (such as polyethylene or the like) to protectcannula 100, reduce friction, or improve flow. In certain configurations,cannula 100 may include structural reinforcement to increase the strength and rigidity of thecannula 100, as shown inFIG. 2 . By way of non-limiting example, such structural reinforcement may comprise athin reinforcement wire 138, which is generally covered by a coating (such as the biocompatible coating discussed above) to provide a smooth surface. - Next, and with reference to
FIGS. 1, 3, and 4 ,reverse flow port 110 is configured to provide blood flow in a different and preferably reverse direction relative to blood flow within thecannula lumen 114 and from theforward flow port 112. For example,FIGS. 3 and 4 show thecannula 100 providing for blood flowing through thecannula lumen 114 from theproximal end 122 ofcannula 100 to theforward flow port 112, and thereverse flow port 110 configured to provide blood flow from thecannula lumen 114 into the blood vessel away from the forward flow port 112 (i.e., away from thedistal end 124 of cannula 100). In a particularly preferred embodiment, and as shown inFIG. 9 , a distal end ofreverse flow port 110 is positioned 5 cm from thedistal end 124 ofcannula 100 so as to ensure adequate flow in both directions without excessive turbulence or other interference between the flows. As discussed in greater detail below, the outer surface ofcap 116 overreverse flow port 110 is further configured to reduce damage (e.g., compared to a typical ECLS cannula) to the patient's tissue (e.g., skin, muscle, and blood vessels) when placing, inserting, or removing thecannula 100. In an embodiment,cannula 100 is placed into a patient's blood vessel according to typical methods and guidelines. Also as discussed in greater detail below,cap 116 overreverse flow port 110 is still further configured to reduce the likelihood that thecannula 100 will inadvertently displace from the patient, for example, whencannula 100 is perturbed or the patient moves, and also reduce damage to the patient's tissue ifcannula 100 is perturbed or inadvertently displaced from the patient, compared to a typical cannula. - In an embodiment,
reverse flow port 110 includes anaperture 130 or hole (seeFIGS. 4, 5, 9, 13, 14, and 17-19 ) extending through the wall ofcannula 100 fromlumen 114 to the exterior ofcannula 100. Theaperture 130 is configured to fluidly communicate blood flow from thecannula lumen 114 to the patient's blood vessel. More particularly, a portion of blood flowing throughlumen 114 towarddistal end 124 ofcannula 100 will escape throughaperture 130 before it reachesdistal end 124 ofcannula 100. The interior ofcap 116 is configured to generally direct blood flow that escapes fromlumen 114 throughaperture 130 in a desired direction, such as a direction opposite to the direction of blood flow from theforward flow port 112, while the exterior ofcap 116 is configured to reduce the likelihood of damage to the patient's tissue, as described herein. The combination of thecap 116 configured as described herein andaperture 130 fluidly communicate blood flow from thecannula lumen 114 to the patient's blood vessel, as described above, while providing preferential blood flow properties, such as desired blood flow velocity and reducing turbulence. Furthermore, in a particular embodiment and as discussed above, thereverse flow port 110 and theforward flow port 112 are spaced relative to each other along thecannula lumen 114, such as by a distance of 5 cm, to reduce the likelihood of damage, etc., as described above (see, e.g.,FIG. 2 ). For example, thereverse flow port 110 can be displaced approximately 5 cm from theforward flow port 112. Thereverse flow port 110 can be displaced approximately 5 cm forward of the insertion point of thecannula 100 into the patient's blood vessel. As a further example, thereverse flow port 110 is displaced distal of an arcuate portion of thecannula 100, such as positioned on a straight portion of thecannula 100. - With continuing reference to
FIGS. 1A, 4-6, and 9-16 , and in accordance with certain aspects of an embodiment,cap 116 is on the exterior ofcannula 100 and generally coversaperture 130. The exterior ofcap 116 generally has a convex, parabolic, and ramp-like shape, such that thecap 116 fluidly communicates blood flow in one direction only. However, in alternative embodiments, thecap 116 can be configured to communicate blood flow in a plurality of directions. As shown in the top views ofcap 116 ofFIGS. 5 and 6 , and in accordance with certain aspects of an embodiment,cap 116 generally has a parabola-like outline, such that it is formed by abody portion 132 that has a ramp-like shape that intersects abottom portion 120 of the exterior ofcannula 100, and a leg portion 134 (e.g., having two leg-like shapes 134 a and 134 b) that generally intersects withside portions 136 of the exterior of cannula 100 (seeFIGS. 5, 6, 6B, and 6C ).Body portion 132 ofcap 116 is generally convex to direct blood flow in a desired direction while reducing the likelihood of inducing turbulence. In an embodiment, the exterior of thebody portion 132 of thecap 116 is generally configured to rest on an inner wall of a patient's blood vessel, such that the inner wall of the blood vessel does not substantially interfere with blood flow betweenaperture 130 and the blood vessel. As best seen inFIG. 1A , the exterior surface ofcap 116 is configured to contact and displace the inner wall of the blood vessel so as to optimally positionaperture 130 with respect to the inner wall of the blood vessel. In a particular embodiment, in order to achieve such optimal positioning ofaperture 130 with respect to the inner wall of the patient's blood vessel to provide optimal flow characteristics, and with reference toFIG. 12 ,cap 116 may have a height (from the exterior ofcannula 100 to the interior face of cap 116) of, for example, between 0.5 mm and 3 mm, and more preferably between 0.8 mm and 2 mm, and most preferably 1 mm, with the wall ofcap 116 having a thickness of preferably between 0.05 mm and 2 mm, and more preferably of 0.2 mm, and a maximum width at a proximal end ofcap 116 of preferably 4 mm. Furthermore, the rounded nature of thebody portion 132 andleg portion 134 provides cap 116 a shape that is configured to slide on the patient's tissue without entangling or snaring the patient's tissue to reduce the likelihood of damage to the patient's tissue when placing thecannula 100 in the patient and when removing thecannula 100 from the patient (e.g., desired or inadvertent), as described above, such thatcap 116 has no substantially sharp, abrupt, or barb-like surfaces. - Further,
body portion 132 andleg portion 134 ofcap 116, in accordance with further aspects of an embodiment, are configured to achieve the desired flow properties. Thebody portion 132 generally forms the parabola-like outline of thecap 116, and extends from thecannula lumen 114 to theleg portion 134 at a ramp angle. The ramp angle (“A” ofFIG. 11 ) ofbody portion 132 ofcap 116 reduces the likelihood of damage to the patient's tissue during insertion by providing a substantially smooth surface, as discussed above. Likewise, the ramp angle (“B” ofFIG. 11 ) ofleg portion 134 ofcap 116 reduces the likelihood of damage to the patient's tissue during removal, with bothbody portion 132 andleg portion 134 having no substantially sharp, abrupt, or barb-like surfaces. In a particular embodiment, the ramp angle A ofbody portion 132 is preferably in the range of 10 degrees to 70 degrees, and more preferably in the range of 15 degrees to 22 degrees. Likewise in a particular embodiment, the ramp angle B of leg portion is preferably in the range of 10 degrees to 70 degrees, and more preferably 20 degrees.Leg portion 134 includes two elongated leg-like features 134 a and 134 b that each extend from thebody portion 132 on thebottom portion 120 ofcannula 100 to theside portions 136 ofcannula 100. Thus,cap 116 is particularly configured to reduce the likelihood of cross-flow (e.g., blood flow in the blood vessel between thereverse flow port 110 and the forward flow port 112) by reducing the likelihood of blood flow around theleg portion 134. Theleg portion 134 is generally angled from theside portions 136 of thecannula lumen 114 to thebody portion 132, such that theleg portion 134 generally has an arcuate and concave outline (best viewed inFIG. 1A ). The angle of theleg portion 134 may vary according to various properties of thecannula 100, such as the cannula lumen diameter, the desired blood flow properties (e.g., direction, velocity, turbulence), and placement location. Furthermore, the angle of theleg portion 134 and concave outline may be selected to reduce the likelihood of damage to the patient's tissue by providing a smooth surface, as discussed above, such as having no substantially sharp, abrupt, or barb-like surfaces. In an alternative embodiment, the leg-like features 134 a and 134 b may have unequal angles and/or arcuate shapes. -
Aperture 130 is configured to fluidly communicate blood flow from thecannula lumen 114 to the patient's blood vessel. In a particular embodiment,aperture 130 of the current embodiment has a parabola-like opening similar to the parabola-like outline of thecap 116, as shown inFIGS. 5 and 14 , in which the vertex of the parabola is located at the distal-most portion of aperture 130 (closest to forward flow port 112). However,aperture 130 may have a different opening size or shape compared to thecap 116. In a particular embodiment,aperture 130 has an opening size that is generally similar to the diameter of thecannula lumen 114, such as 12-23 French. For example,FIG. 5 shows a top view of cap 116 (shaded) and aperture 130 (dashed line) that do not strictly overlap, but have a generally similar outline. In a particular embodiment and as shown inFIG. 18 , theaperture 130 has an opening that is approximately 4 mm wide and approximately 7 mm long. Alternatively,aperture 130 may have an ellipsoidal-like opening as shown inFIG. 4 . - Now referring to FIGS, 1-3, 7-9, and 19, forward flow
port 112 is configured to fluidly communicate blood from thecannula lumen 114 into the patient's blood vessel in a proximal direction (e.g., towards the heart and other arteries). In accordance with a particular embodiment, forward flowport 112 has a cross-sectional opening that is similar to the cross-section ofcannula 100, whilereverse flow port 110 is configured to communicate blood flow from thecannula lumen 114 into the blood vessel away from the forward flow port 112 (e.g., away from thedistal end 124 of cannula 100). In other configurations, forward flowport 112 may include a plurality of apertures or fenestrations. - Coupling 118 adjacent
proximal end 122 ofcannula 100 may be configured to attach to standard medical equipment, such as ECLS devices or any device for circulating blood through a major blood vessel having blood flow in an opposing direction, such as cardiac bypass, mechanical arterial support, venous access device (VAD) support, or the like. - Next, and with reference to
FIGS. 20 and 21 , anobdurator 200 may be provided for use withcannula 100 for placement ofcannula 100 within a patient's blood vessel.Obdurator 200 is a solid member having an outside diameter approximately the same as the inside diameter ofcannula lumen 114 at thedistal end 124 ofcannula 100, and is sufficiently long so that thedistal end 202 ofobdurator 200, when inserted incannula 100, extends beyond thedistal end 124 of cannula100. In use, access may be gained to the vessel (such as by making an incision) and theobdurator 200 is inserted intocannula 100, withdistal end 202 ofobdurator 200 extending beyond thedistal end 124 ofcannula 100.Obdurator 200 then pushes through the patient's soft tissue and into the patient's blood vessel, gaining entrance forcannula 200. Once inserted in place,obdurator 200 is removed, leavingcannula 100 in place in the patient's blood vessel. -
Obdurator 200 is particularly configured to enable an operator to know whenreverse flow port 110 is positioned within the patient's blood vessel. More particularly,obdurator 200 includes aconcave channel 204 extending into the surface ofobdurator 200. Concave channel has a distal end closest todistal end 124 oflumen 114 that, when obdurator 200 is fully inserted intocannula 100, aligns with or is distal to reverse flow port 110 (as show inFIG. 20 ).Channel 204 allows blood to flow incannula 100 when obdurator 200 is in place withincannula 100, with such blood flowing from the patient's blood vessel intoreverse flow port 110, intochannel 204, and proximally through channel 204 (toward theproximal end 122 of cannula 100) into awidened section 138 ofcannula 100 and ultimately toward preferably a luer locked hole (not shown) positioned near proximal end ofcannula 100, such as oncoupling 118. Withobdurator 200 completely inserted intocannula 100, the distal end ofconcave channel 204 aligns withreverse flow port 110. Asreverse flow port 110 enters the patient's blood vessel, arterial pressure will push blood throughreverse flow port 110, intoconcave channel 204 inobdurator 200, and fill theempty lumen 114 ofcannula 100 to finally exit out of the luer locked hole near theproximal end 122 ofcannula 100. In a particular configuration,concave channel 204 has a depth into the surface ofobdurator 200 and a width that is 5-30% of the diameter ofobdurator 200. - Disclosed above is a bidirectional intravascular cannula, or catheter, that is configured to provide and return blood bidirectionally. The bidirectional intravascular cannula reduces or obviates the need for a second cannula to be placed in a second or opposite direction of flow of currently available unidirectional cannulae. The cannula is further configured to be inserted into the patient at an insertion location while reducing damage to tissue, compared to typical cannula, which is adjacent to that insertion location. This bidirectional intravascular cannula provides bidirectional flow via a biocompatible, reverse flow port. The cannula is further configured to stably remain in the patient at the insertion location of the patient when perturbed, such as when the patient moves slightly or when a line coupled to the cannula is perturbed. This bidirectional intravascular cannula provides bidirectional flow via a reverse flow port and the forward flow port, which are biocompatible.
- While the exemplary embodiments have been shown and described, it will be understood by those skilled in the art that various changes in form and details may be made thereto without departing from the spirit and scope of the present disclosure as defined by the appended claims.
- In addition, many modifications can be made to adapt a particular situation or material to the teachings of the present disclosure without departing from the essential scope thereof Therefore, it is intended that the present disclosure not be limited to the particular exemplary embodiments disclosed as the best mode contemplated for carrying out the present disclosure, but that the present disclosure will include all embodiments falling within the scope of the appended claims.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/844,990 US20220313888A1 (en) | 2017-10-10 | 2022-06-21 | Bidirectional flow catheter |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762570148P | 2017-10-10 | 2017-10-10 | |
PCT/US2018/055160 WO2019075020A1 (en) | 2017-10-10 | 2018-10-10 | Bidirectional flow catheter |
US202016754382A | 2020-04-08 | 2020-04-08 | |
US17/844,990 US20220313888A1 (en) | 2017-10-10 | 2022-06-21 | Bidirectional flow catheter |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2018/055160 Continuation WO2019075020A1 (en) | 2017-10-10 | 2018-10-10 | Bidirectional flow catheter |
US16/754,382 Continuation US11364333B2 (en) | 2017-10-10 | 2018-10-10 | Bidirectional flow catheter |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220313888A1 true US20220313888A1 (en) | 2022-10-06 |
Family
ID=66101667
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/754,382 Active 2038-12-26 US11364333B2 (en) | 2017-10-10 | 2018-10-10 | Bidirectional flow catheter |
US17/844,990 Abandoned US20220313888A1 (en) | 2017-10-10 | 2022-06-21 | Bidirectional flow catheter |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/754,382 Active 2038-12-26 US11364333B2 (en) | 2017-10-10 | 2018-10-10 | Bidirectional flow catheter |
Country Status (3)
Country | Link |
---|---|
US (2) | US11364333B2 (en) |
EP (1) | EP3694577A4 (en) |
WO (1) | WO2019075020A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3735996B1 (en) | 2019-05-07 | 2023-09-27 | Free Life Medical GmbH | Bi-directional perfusion cannula |
USD975844S1 (en) | 2019-11-06 | 2023-01-17 | Free Life Medical Gmbh | Cannula |
TWI724682B (en) * | 2019-12-11 | 2021-04-11 | 林伯彥 | Bidirectional vascular tube device |
EP4108268A1 (en) | 2021-06-22 | 2022-12-28 | Jawad Salman | Bi-directional cannula |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130085438A1 (en) * | 2011-09-30 | 2013-04-04 | Tyco Healthcare Group Lp | Hemodialysis catheter with improved side opening design |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4973321A (en) | 1989-03-17 | 1990-11-27 | Michelson Gary K | Cannula for an arthroscope |
US5171218A (en) | 1992-01-02 | 1992-12-15 | Trustees Of Boston University | Bidirectional femoral arterial cannula |
CA2218105A1 (en) | 1995-03-30 | 1996-10-03 | Heartport, Inc. | Endovascular cardiac venting catheter and method |
US6186981B1 (en) | 1999-03-23 | 2001-02-13 | Peter Cho | Cavo-atrial cannula |
US7393339B2 (en) | 2003-02-21 | 2008-07-01 | C. R. Bard, Inc. | Multi-lumen catheter with separate distal tips |
WO2005046778A1 (en) | 2003-11-06 | 2005-05-26 | Radius International Limited Partnership | Catheter and method of manufacture |
GB2437254B (en) | 2006-04-13 | 2010-11-17 | Haemair Ltd | Blood/air mass exchange apparatus |
WO2007124340A2 (en) * | 2006-04-21 | 2007-11-01 | Medrad, Inc. | Improvements in central venous catheters and related equipment |
US7993525B2 (en) | 2006-12-29 | 2011-08-09 | Intel Corporation | Device and method for particle complex handling |
US8092415B2 (en) | 2007-11-01 | 2012-01-10 | C. R. Bard, Inc. | Catheter assembly including triple lumen tip |
US8795253B2 (en) | 2011-04-05 | 2014-08-05 | Sorin Group Italia S.R.L. | Bi-directional perfusion cannula |
CN105358206B (en) * | 2013-06-04 | 2019-03-12 | 迈克尔·加布里埃尔·塔尔 | Double pointed end hemodialysis catheter |
US9981119B2 (en) | 2014-10-29 | 2018-05-29 | Edwards Lifesciences Corporation | Bi-directional cannula |
KR20160103474A (en) | 2015-02-24 | 2016-09-01 | 사회복지법인 삼성생명공익재단 | Femoral arterial Cannula capable of guidance of bidirectional flow |
-
2018
- 2018-10-10 EP EP18866864.4A patent/EP3694577A4/en active Pending
- 2018-10-10 US US16/754,382 patent/US11364333B2/en active Active
- 2018-10-10 WO PCT/US2018/055160 patent/WO2019075020A1/en unknown
-
2022
- 2022-06-21 US US17/844,990 patent/US20220313888A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130085438A1 (en) * | 2011-09-30 | 2013-04-04 | Tyco Healthcare Group Lp | Hemodialysis catheter with improved side opening design |
Also Published As
Publication number | Publication date |
---|---|
US11364333B2 (en) | 2022-06-21 |
US20200306440A1 (en) | 2020-10-01 |
EP3694577A1 (en) | 2020-08-19 |
EP3694577A4 (en) | 2021-07-07 |
WO2019075020A1 (en) | 2019-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220313888A1 (en) | Bidirectional flow catheter | |
US11918725B2 (en) | Dual lumen cannula | |
US10124100B2 (en) | Ventricular assist device and related methods | |
US10729831B2 (en) | Inflow cannula tunneling tool allowing quick exchange with dilating plug | |
AU2007200797B2 (en) | A pump-inflow-cannula, a pump-outflow-cannula and a blood managing system | |
US7491163B2 (en) | Multilumen catheter for minimizing limb ischemia | |
US8579791B2 (en) | Ventricular assist device and related methods | |
US20060270895A1 (en) | Multilumen catheter for minimizing limb ischemia | |
US20140018772A1 (en) | Self-centering catheter with anti-occlusion features | |
JP2002515301A (en) | Pulmonary and systemic blood flow support devices and methods for cardiac surgical procedures | |
AU2007200798A1 (en) | A pump-inflow-cannula, a pump-outflow-cannula and a blood managing system | |
US7524277B1 (en) | Apex to aorta cannula assembly | |
AU2002214653A1 (en) | A multilumen catheter for minimizing limb ischemia | |
US20010000528A1 (en) | Cavo-atrial cannula and method of use | |
CA2391214C (en) | Venous return cannula with enhanced drainage | |
US20230107515A1 (en) | Method of converting a femoral venous cannula | |
JP2021529054A (en) | Vascular access tube | |
US20190255234A1 (en) | Cannula, cannula system, heart pump system and method for relieving the volume of a heart | |
WO2022207505A3 (en) | Devices for fistula-free hemodialysis | |
JP2023503417A (en) | Bi-directional arterial cannula for extracorporeal membrane oxygenator and method of using such cannula | |
JP2022532767A (en) | Blood pumps and related devices, systems, and methods delivered intravascularly | |
US20220273857A1 (en) | Novel type superior vena cava cannula for use in extrathoracic cannulation in open heart surgery | |
JP7445751B2 (en) | Vascular access system and method | |
US20220280768A1 (en) | Cannula for Endovascular Blood Circuit Support, Corresponding Assembly, Method and Cannula System | |
AU2008200502B2 (en) | A Multilumen Catheter for Minimizing Limb Ischemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: UNIVERSITY OF MARYLAND MEDICAL CENTER, LLC, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PASRIJA, CHETAN;GHOREISHI, MEHRDAD;BITTLE, GREGORY;SIGNING DATES FROM 20190717 TO 20191003;REEL/FRAME:060366/0610 Owner name: UNIVERSITY OF MARYLAND, BALTIMORE, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KON, ZACHARY;GRIFFITH, BARTLEY;SIGNING DATES FROM 20181114 TO 20190116;REEL/FRAME:060366/0542 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |